Parameters | OR (95% CI) | P value |
---|---|---|
Clinical N stage(≥ cN1 vs. cN0) | 0.517(0.249 ~ 1.073) | 0.077 |
HR status (negative vs. positive) | 2.252(1.172 ~ 4.323) | 0.015 |
HER2 status (3 + vs. 2 +) | 4.576(1.682 ~ 12.449) | 0.003 |
Cycles of targeted treatment (> 4 vs. 4) | 1.841(0.925 ~ 3.664) | 0.066 |